globenewswire

Inovalon Reports Second Quarter 2020 Results Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 11:10
Second Quarter 2020 Highlights Q2 revenue of $162.2 million, up 3% YoYQ2 subscription-based platform revenue of $142.1 million, up 13% YoY, equating to 88% of Q2 total revenueQ2 net income of $2.0 million, resulting in diluted net income of $0.01 per shareQ2 Non-GAAP net income of $22.0 million, up 15% YoY, resulting in Non-GAAP net income of $0.15 per shareQ2 Adjusted EBITDA of $56.6 million, up 8% YoY, resulting in Adjusted EBITDA margin of 34.9%Q2 net cash provided by operating activities of $49.0 millionQ2 new sales Annual Contract Value (ACV)1 totaled a record $75.7 million, up 38.1% YoY Debt & Cash Highlights Voluntarily repaid $99 million (100% of all outstanding amounts) of revolver on June 4, 2020Cash balance as of June 30, 2020 totaling $95.6 millionNet debt leverage ratio as of June 30, 2020 improved to 3.69x (versus 4.32x on June 30, 2019) Trailing Twelve Month (TTM)2 Second Quarter 2020 Highlights TTM Q2 revenue of $656.3 million, up 12% period-over-periodTTM Q2 subscription-based platform revenue of $563.1 million up 17% period-over-period, equating to 86% of period revenueTTM Q2 net income of $11.9 millionTTM Q2 Non-GAAP net income of $81.9 million, up 42% period-over-periodTTM Q2 Adjusted EBITDA of $218.0 million, up 16% period-over-periodTTM Q2 net cash provided by operating activities of $129.7 millionTTM Q2 new sales ACV totaled $238.7 million 2020 Guidance Highlights Raising low end of revenue range, and increasing Adjusted EBITDA and Non-GAAP diluted earnings per share guidance for full year 2020Providing third quarter 2020 guidance Please refer to our Second Quarter 2020 Earnings Presentation Supplement available at http://investors.inovalon.com for additional information, 2020 financial guidance, additional financial metrics, and other topics that will be referenced during the Company’s conference call. BOWIE, Md. , July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 11:05
SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 08:30
NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Medical Laser Market to Exhibit CAGR of 13.9% by 2027; Accountable to Rising Prevalence of Coronary Artery Diseases: Fortune Business Insights™ Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 07:21
Pune, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
KOELIS Announces Partnership with GMP, Providing VA Hospitals with Access to Advanced Prostate Care Technology Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 07:01
PRINCETON, N.J., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Telehealth Market to Exhibit 25.2% CAGR till 2027; Rising Preference for E-visits Owing to Their Cost-effectiveness will Boost Growth: Fortune Business Insights™ Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 05:31
Pune, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
DNV GL Receives Deeming Authority to Accredit Psychiatric Hospitals Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 05:21
Milford, Ohio, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Verata Health and Olive Join Forces to Solve $31B Prior Authorization Issue Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 04:00
MINNEAPOLIS, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 04:00
VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Philips launches pre-hospital wireless monitoring solution for emergency medical response in U.S. Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 04:00
July 29, 2020 Philips receives 510(k) clearance from the FDA for its professional defibrillator (Tempus LS- Manual), now offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.Solution delivers real-time bidirectional data transfer for remote patient monitoring, giving EMS responders a new approach to pre-hospital care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders. The professional defibrillator (Tempus LS-Manual) is the final element of the overall solution to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the U.S. market. As a unique modular platform, the remote monitoring and defibrillator solution (Tempus ALS) consists of a remote portable vital signs patient monitor (Tempus Pro), and remote professional defibrillator (Tempus LS-Manual). While the monitor and defibrillator can be used separately, the devices also connect wirelessly to share data and transfer vitals, waveforms and images into Philips web-based software platform (IntelliSpace Corsium). The software platform provides robust, real-time transfer of clinical data and events, interactive ECG measurement, two-way communication and more, enabling rapid clinical and transport decision support and seamless electronic patient care recording (ePCR) integration outside the hospital in emergency settings. “In emergency situations, where seconds count, having access to advanced patient data collection and sharing and real-time secure data streaming, can help inform confident treatment and transport decisions outside the hospital,” said Arman Voskerchyan, General Manager of Therapeutic Care at Philips. “The integrated remote monitoring and defibrillator solution combined with our web-based software platform will help front line responders provide emergency care, diagnosis and treatment - including defibrillation therapy, data management and clinical and operational efficiency features – in a fully integrated solution.” Emergencies and care events outside the hospital continue to rise, with an estimated 240 million calls made to 9-1-1 in the U.S. each year [1]. In addition to the stress of the unknown and what to expect at the scene of the call, emergency medical providers must deal with manual handling issues. Equipment carried is heavy, often damaged due to use in unpredictable conditions and has limited data connectivity – inhibiting the ability for on-scene support. In an effort to address these challenges, both elements of the Philips remote monitoring and defibrillator (Tempus ALS) solution are designed with a small, rugged exterior and long-lasting battery to allow emergency medical providers to focus on caring for the patient without the hassle or distraction of bulky equipment. Philips leadership in Emergency Care solutions Earlier this year, Philips launched its new emergency care informatics suite in the U.S. market, previously in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology. In October 2019, Philips announced a first-of-its-kind collaboration with Air Ambulance Kent Surrey Sussex (AAKSS) where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a wide range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more. Visit Philips Emergency Care and Resuscitation for more information on the remote monitoring and defibrillator solution and Philips broad portfolio of Emergency Care solutions. [1] https://www.nena.org/page/911Statistics For further information, please contact: Kathy O'Reilly  Philips Global Press OfficeTel: +1 978-221-8919E-mail :  This e-mail address is being protected from spambots. You need JavaScript enabled to view it About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at
Read more...
 
Conversion Labs to Host Second Quarter Conference Call on Monday, August 17, 2020 at 1:00 p.m. ET Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 03:31
NEW YORK, July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
InveniAI Enters Strategic Artificial Intelligence (AI) and Machine Learning (ML) Focused Collaboration with GlaxoSmithKline Consumer Healthcare Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 03:30
Three-year strategic collaboration to leverage InveniAI’s AI- and ML-powered Platform, AlphaMeld® after a successful proof-of-value collaborationAlphaMeld® will capture consumer-specific innovation for both internal and external R&D GUILFORD, Conn., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
Auris Medical Announces Completion of Enrollment into First Part of TRAVERS Phase 2 Study with AM-125 in Vertigo Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 03:30
Read more...
 
Smile Direct Club Now Serving Orthodontia’s Largest and Fastest-Growing Segment: Teens Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 03:29
SmileDirectClub Teen program expands medtech pioneer’s mission to increase access to premium oral care New offering includes groundbreaking, patented aligner case powered by Tile™ NASHVILLE, Tenn., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests Print E-mail
By GLOBE NEWSWIRE   
Wednesday, 29 July 2020 03:26
SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE)
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 170

Newsletter